Eric Jackson

Sr. Director, Managed Markets, Access & Pricing at Urovant Sciences

Eric Jackson has over 20 years of experience in various roles within the pharmaceutical industry. Eric has held senior leadership positions at companies like Amgen, ACADIA Pharmaceuticals Inc., and Urovant Sciences, Inc., focusing on managed markets, access, and pricing. Prior to this, Eric worked at KPMG, where they managed Sarbanes-Oxley related client services, and at Ernst & Young, where they worked as an IT & Financial Auditor. Throughout their career, Eric has demonstrated a strong track record of developing and implementing pricing strategies, negotiating contracts, and ensuring compliance with government regulations.

Eric Jackson holds a Bachelor's Degree in Accounting from Brigham Young University. Eric continued their education at the same university and earned a Master's Degree in Information Systems. Additionally, Eric is a Certified Public Accountant.

Location

Newport Beach, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Urovant Sciences

Urovant Sciences, innovations in urology. Our lead therapeutic candidate is vibegron (RVT-901), an investigational oral β3-adrenergic agonist


Industries

Employees

11-50

Links